← Open Payments lookup

GILDA MARK: Open Payments

NPI 1700124617 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,673 in 65 payments from 9 companies in 2025. Trend: 2023 $2,097 · 2024 $2,030 · 2025 $2,673

Food & beverage: $2,607Education: $66
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$867
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$729
Alkermes, Inc.9$410
E.R. Squibb & Sons, L.L.C.8$296
Teva Pharmaceuticals USA, Inc.7$202
Otsuka America Pharmaceutical, Inc.3$82
Otsuka Pharmaceutical Development & Commercialization, Inc.1$44
ABBVIE INC.1$25
Janssen Scientific Affairs, LLC1$18

Products named: INGREZZA, CAPLYTA, COBENFY, LYBALVI, ARISTADA, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI.

Industry payments across CO — which companies pay providers there.